Efficacy and Antiglycemic Activity of m. Charantia Ripe Fruit in the Correction of Induced Diabetes

Tchogou Atchadé Pascal¹, Assou Cendra^{1, 2}, Agbogba Félicienne^{1, 2}, Agniwo Privat², Medoatinsa Espérance¹, Abissi Yollande¹, Lokonon Jacques Ezéchiel¹, Hlouedje Wilfried¹, Houngbeme Alban³, Gbenou Joachim⁴, Anago Eugénie² and Senou Maximin^1,

¹Unité de Biologie Expérimentale et Clinique (UBEC), Laboratoire de Recherche en Biotechnologie Médicale et Pharmaceutique (LaRBiMeP), Ecole Nationale Supérieure des Biosciences et Biotechnologie Appliquées de Dassa-Zoumé (ENSBBA), Université Nationale des Sciences, Technologies, Ingénierie et Mathématiques d’Abomey (UNSTIM).

²Laboratoire de Biologie Appliquée (LARBA), École Polytechnique d’Abomey-Calavi (EPAC), Université d’Abomey-Calavi (UAC), R Bénin.

³Laboratoire National de Pharmacognosie/Centre Béninois de la Recherche Scientifique et Technique (CBRST). BP 06 Oganla Porto-Novo.

⁴Ecole doctorale (ED-STIM), Université Nationale des Sciences, Technologies, Ingénierie et Mathématiques (UNSTIM).

Cite this paper:
Tchogou Atchadé Pascal, Assou Cendra, Agbogba Félicienne, Agniwo Privat, Medoatinsa Espérance, Abissi Yollande, Lokonon Jacques Ezéchiel, Hlouedje Wilfried, Houngbeme Alban, Gbenou Joachim, Anago Eugénie and Senou Maximin. Efficacy and Antiglycemic Activity of m. Charantia Ripe Fruit in the Correction of Induced Diabetes. American Journal of Biomedical Research. 2023; 11(1):27-34. doi: 10.12691/ajbr-11-1-4

Abstract

Momordica charantia (M. charantia) is a plant widely used in traditional medicine to treat a number of pathologies, particularly diabetes mellitus. The pharmacological properties of this plant have been demonstrated through the wide variety of its phytochemical components. However, it is very important to know which part of the plant contains the most phytochemical components and biological activity. The aim of this study is to demonstrate the effect on type 1 diabetes in rats and the anti-glycaemic activity of M. charantia ripe fruit extract. Phytochemical screening of ripe fruit was carried out using staining and precipitation reactions. Diabetes was induced in rats by injection of five doses of streptozotocin (40 mg/kg) body weight. Efficacy in animals was tested by treating them with the extracts for 28 consecutive days at 10mg/L. The spectrophotometer and a haematology device were used to assay biochemical and haematological parameters respectively. Histological sections were taken following fixation of pancreas with 10% formalin and staining with hematoxylin-eosin (HE). Five secondary metabolites (alkaloids, reducing compounds, saponosides, triterpenes and steroids) were found in the ripe fruit extract. A weak corrective effect on glycemia, and pancreatic necrosis was demonstrated. A corrective activity on HDL hypocholesterolemia and hypercreatininemia associated with diabetes was also observed. Ripe fruit extract of Momordica charantia displayed a moderate antidiabetic activity.

Keywords:
diabetes momordica charantia ripe fruit african

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

Figures

References:

[1]	American Diabetes Association, 2451 Crystal Drive, Suite 900, Arlington, VA 22202. 2010.
[2]	Amos, A, McCarthy, D, and Zimmet, P, “The rising global burden of diabetes and its complications; estimates and projections to the year 2010.,” Diabet. Med, pp. 14, S1–S85, 1997.
[3]	Zimmet, P, “Globalization, coca-colonization and the chronic dis_ease epidemic: can the Doomsday scenario be averted?,” J. Intern. Med., pp. 247, 301-310., 2000.
[4]	Zimmet, P, Shaw, J, and Alberti, K. G, “Preventing Type 2 diabetes and the dysmetabolic syndrome in the real world: a realistic view.,” Dia_bet. Med., pp. 20, 693–70., 2003.
[5]	WHO, “Global Report on Diabetes. World Health Organization, Geneva,.” pp. 1-88., 2016.
[6]	Liu, Z, Gong, J, Huang, W, Lu, F, and Dong, H, “The Effect of Momordica charantia in the Treatment of Diabetes Mellitus: A Review,” Evidence-based Complement. Altern. Med., 2021.
[7]	Van Der Vliet H. J, Von Blomberg, B. M. E, Nishi, N, Reijm, M, Voskuyl, A. E, Van Bodegraven, A. A, Pinedo, H. M, “Circulating Vα24+ Vβ11+ NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage.,” Clin. Immunol., pp. 100(2), 144-148., 2001.
[8]	Gale E. A, “The rise of childhood type 1 diabetes in the 20th century.” 2002.
[9]	Acharjee, A. B, Ghosh, S, , Al-Dhubiab, B, , & Nair, B. E, “Understanding type 1 diabetes: etiology and models. ,” Can. J. diabetes, pp. 37(4), 269-276., 2013.
[10]	Furman, B. L, Candasamy, M, Bhattamisra S. K, and Veettil S. K, “Reduction of blood glucose by plant extracts and their use in the treatment of diabetes mellitus; discrepancies in effectiveness between animal and human studies.,” J. Ethnop, 2020.
[11]	Świątoniowska, N, Sarzyńska K, Szymańska-Chabowska A, and Jankowska-Polańska B, “The role of education in type 2 diabetes treatment. ,” Diabetes Res. Clin. Pract., no. 2016, pp. 151, 237-246., 2019.
[12]	Singh, J, Cumming, E, Manoharan, G, Kalasz, H, and Adeghate, E, “Medicinal Chemistry of the Anti-Diabetic Effects of Momordica Charantia: Active Constituents and Modes of Actions,” Open Med. Chem. J., vol. 5, no. Suppl 2, pp. 70–77, 2011.
[13]	Palamthodi, S. S, Lele S, “Nutraceutical applications of gourd family vegetables: Benincasa hispida, Lagenaria siceraria and Momordica charantia.,” Biomed. Prev. Nutr., pp. 4(1), 15-21., 2014.
[14]	Hsiao P. C, Von Blomberg, B. M. E, Nishi, N, Reijm, M, Voskuyl, A. E, Van Bodegraven, A. A, Pinedo, H. M, “Antiproliferative and hypoglycemic cucurbitane-type glycosides from the fruits of Momordica charantia.,” J. Agric. Food Chem., vol. 1, pp. 61(12), 2979-2986., 2013.
[15]	Park, S. H, Yi, Y. S, Kim, M. Y, and Cho, J. Y, “Antioxidative and antimelanogenesis effect of Momordica charantia methanol extract.,” Evidence-Based Complement. Altern. Med., 2019.
[16]	Jia, J, Shen, S, Zhang, M, Xie, F, “Recent advances in Momordica charantia: functional components and biological activities. ,” Int. J. Mol. Sci., pp. 18(12), 2555., 2017.
[17]	Assou, C, Anago, E, Senou, M, Agniwo, P, Ezéchiel, L, Jacques, H. W, Tchogou, P, Houngbeme, A, Akpovi D. C, Gbenou J, “Anti-hyperglycemic effect of Momordica charantia green fruit extract,” Int. J. Pharm. Sci. Invent., vol. 11, no. 5, pp. 6–16, 2022.
[18]	Senou, M, Khalifa, C, Thimmesch, M, Jouret, F, Devuyst, O, Audinot, V, Lipnik, J. N, et al., “A coherent organization of differentiation proteins is required to maintain an appropriate thyroid function in the pendred thyroid,” J. Clin. Endocrinol. Metab., vol. 95, no. 8, pp. 4021–4030, 2010.
[19]	Aljohi, N, Matou-Nasri, A, Ahmed, S, “Antiglycation and antioxidant properties of Momordica charantia.,” PLoS One, pp. 11(8), e0159985, 2016.
[20]	Ahmed, H. R. I, Lakhani, M.S, Gillett, M, John, A, “Hypotriglyceridemic and hypocholesterolemic effects of anti- diabetic Momordica charantia ( karela ) fruit extract in streptozotocin-induced diabetic rats,” Diabetes Res. Clin. Pract., pp. 155–161, 2000.
[21]	Gurav, A, Mondal, D. B, and Vijayakumar, H, “In vitro qualitative and quantitative phytochemical analysis of ethanolic and 50% ethanolic extracts of Tinospora cordifolia, Momordica charantia, Cucurbita maxima and Raphanus sativus,” 2014, pp. 4–6.
[22]	Fachinan, R, Fagninou, A, Nekoua, M. P, Amoussa, A. M, Adjagba, M, Lagnika, L, Lalèyè, A et al.,“Evidence of immunosuppressive and Th2 immune polarizing effects of antidiabetic Momordica charantia fruit juice,” Biomed Res. Int., vol. 2017, 2017.
[23]	A. L. . Sattiel and C. R. Khan, “In insulin signalling and regulation of glucose and lipid metabolism.,” Nature, pp. 414, 799–806, 2001.
[24]	Kumar, P. J, and Clark, M, “Diabetes mellitus and other disorders of metabolism.,” Extb. Clin. Med. Saunders, pp. 1069–1121, 2005.
[25]	Platel, K, and Srinivasan, K, “Effect of dietary intake of freeze-dried bitter gourd (Momordica charantia) in streptozotocin induced dia_betic rats.,” Nahrung, pp. 39, 262–268, 1997.
[26]	Sharma A. K, et al., “The beneficial effects of Momordica charantia fruit juice on streptozotocin –induced diabetes and hyper_tension in rats.,” Int. J. Diabetes, pp. 4, 29, 1996.
[27]	Shibib B. A, Khan, L. A and Rahman, R, “Hypoglycaemic activity enzymes glucose-6-phosphatase and fructose-1,6-bisphosphatase and elevation of both liver and red-cell shunt enzyme glucose-6- phosphate dehydrogenase.,” Biochem. J., pp. 292, 267–270, 1993.
[28]	C. Assou Anago, E, Agbogba, F, Agniwo, P, Abissi, Y, Gbénou, J, Sènou, M, “Efficacy of M . charantia Leaves in the Correction of Induced Diabetes .,” Am. J. Med. Sci. Med., vol. 11, no. 3, pp. 74–79, 2023.
[29]	Chaturvedi, P, George, S, Milinganyo, M, and Tripathi, Y. B, “Effect of Momordica charantia on lipid profile and oral glucose tolerance in diabetic rats. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives.” pp. 18(11), 954-956., 2004.
[30]	Taylor, L, “Bitter Melon (Momordica charantia). , 2002,” Herb. Secrets Rainforest. 2nd Ed. Sage Press. Austin Texas, USA, pp. 1–100, 2002.
[31]	Ahmed, I, Cummings, E, Sharma, A. K, Adeghate, E, and Singh, J, “Beneficial effects and mechanism of action of Momordica charantia fruit juice in the treatment of streptozotocin-induced diabetes mellitus in rats.,” Mol. Cell Biochem., pp. 261, 63-70., 2004.
[32]	Ahmed, I, Adeghate, E, Sharma, A. K, Pallot, D. J, and Singh, J, “Effects of Momordica charantia fruit juice on islet morphology in the pancreas of the streptozotocin-diabetic rat.,” Diabetes Res. Clin. Pr., pp. 40, 145–151, 1998.
[33]	Oso, B, Agboola, O, andOlaoye, I, “Glycation Inhibition of Bovine Serum Albumin by Extracts of Momordica charantia L. using Spectroscopic and Computational Methods,” Avicenna J. Med. Biotechnol., vol. 15, no. 3, pp. 180–187, 2023.